Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Noonan Syndrome 5 × tovorafenib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Low-grade Glioma 3 Pancreatic Neoplasms 2 Melanoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Astrocytoma 2 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Noonan Syndrome 5 1 Leukemia, Hairy Cell 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Craniopharyngioma 1 Brain Neoplasms 1

Interventions

tovorafenib 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05566795 2026-03-02

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Day One Biopharmaceuticals, Inc.

Phase 3 Recruiting

Noonan Syndrome 5

Data powered by HemOnc (CC BY 4.0) Colophon ⚡